Cis-regulatory variants affect CHRNA5 mRNA expression in populations of African and European ancestry.
- Authors
- Wang, Jen-Chyong; Spiegel, Noah; Bertelsen, Sarah; Le, Nhung; McKenna, Nicholas; Budde, John P; Harari, Oscar; Kapoor, Manav; Brooks, Andrew; Hancock, Dana; Tischfield, Jay; Foroud, Tatiana; Bierut, Laura J; Steinbach, Joe Henry; Edenberg, Howard J; Traynor, Bryan J; Goate, Alison M
- Year
- 2013
- Journal
- PloS one
- PMID
- 24303001
- DOI
- 10.1371/journal.pone.0080204
- PMCID
- PMC3841173
Variants within the gene cluster encoding Ξ±3, Ξ±5, and Ξ²4 nicotinic receptor subunits are major risk factors for substance dependence. The strongest impact on risk is associated with variation in the CHRNA5 gene, where at least two mechanisms are at work: amino acid variation and altered mRNA expression levels. The risk allele of the non-synonymous variant (rs16969968; D398N) primarily occurs on the haplotype containing the low mRNA expression allele. In populations of European ancestry, there are approximately 50 highly correlated variants in the CHRNA5-CHRNA3-CHRNB4 gene cluster and the adjacent PSMA4 gene region that are associated with CHRNA5 mRNA levels. It is not clear which of these variants contribute to the changes in CHRNA5 transcript level. Because populations of African ancestry have reduced linkage disequilibrium among variants spanning this gene cluster, eQTL mapping in subjects of African ancestry could potentially aid in defining the functional variants that affect CHRNA5 mRNA levels. We performed quantitative allele specific gene expression using frontal cortices derived from 49 subjects of African ancestry and 111 subjects of European ancestry. This method measures allele-specific transcript levels in the same individual, which eliminates other biological variation that occurs when comparing expression levels between different samples. This analysis confirmed that substance dependence associated variants have a direct cis-regulatory effect on CHRNA5 transcript levels in human frontal cortices of African and European ancestry and identified 10 highly correlated variants, located in a 9 kb region, that are potential functional variants modifying CHRNA5 mRNA expression levels.
Minor allele of rs880395 (A allele), rs3841324 (S allele) and rs588765 (T allele) are associated with increased total mRNA expression of CHRNA5 in human frontal cortex of African Americans.
LLM interpretation
This figure consists of three scatter plots showing the relative total mRNA expression of *CHRNA5* (log transformed) across different genotypes for three single nucleotide polymorphisms (SNPs): rs880395, rs3841324, and rs588765. In all three plots, mRNA expression levels decrease as the number of minor alleles (A for rs880395, S for rs3841324, and T for rs588765) decreases. Each plot includes individual data points with mean and error bars for the respective genotype groups.
Allele specific expression (ASE) analysis with rs16969968 in 44 frontal cortices of European ancestry.2a. Davies-Bouldin (DB) validity index analysis. Columns represent the ASE. Dotted line represents the DB validity index. The red dot indicates the optimal cutoff predicted by the DB index that coincides with ASE. 2b. Concordance of allelic expression variation with heterozygosity. Samples #1 to #14 which show relative allelic expression balance (*ASE<2) are homozygous for the 13 highlighted SNPs. Samples #15 to #44 which show relative allelic expression imbalance are heterozygous for all 13 SNPs. *See material and method for details; ASE: allele specific expression. β Indicates samples are also heterozygous for rs615470.
LLM interpretation
Figure 2a is a combined bar and line chart showing relative allele-specific expression (ASE) and the Davies-Bouldin (DB) validity index across subjects, with a red dot marking the optimal ASE cutoff. Figure 2b is a heatmap/table displaying the concordance of allelic expression variation with heterozygosity for 13 highlighted SNPs across 44 samples. Samples 1β14 exhibit balanced ASE (<2) and are homozygous for the 13 SNPs, while samples 15β44 exhibit imbalanced ASE and are heterozygous for the same SNPs.
Allele specific expression (ASE) analysis with rs615470 in 45 frontal cortices of European ancestry.3a. Davies-Bouldin (DB) validity index analysis. Columns represent the ASE. Dotted line represents the DB validity index. The red dot indicates the optimal cutoff predicted by the DB index that coincides with ASE. 3b. Concordance of allelic expression variation with heterozygosity. Samples #1 to #6 which show relative allelic expression balance (*ASE<2) are homozygous for the 13 highlighted SNPs. Samples #7 to #45 which showed relative allelic expression imbalance are heterozygous for all 13 SNPs. *See material and method for details; ASE: allele specific expression. β Indicates samples are also heterozygous for rs16969968.
LLM interpretation
Figure 3a is a combined bar and line graph showing relative allele-specific expression (ASE) for rs615470 across subjects, with a superimposed line representing the Davies-Bouldin (DB) validity index; a red dot marks the optimal cutoff where the DB index is minimized. Figure 3b is a genotype heatmap and table comparing 45 samples, showing that samples 1β6 with balanced ASE are homozygous for 13 highlighted SNPs, while samples 7β45 with imbalanced ASE are heterozygous for those same SNPs. The x-axis of 3a represents individual subjects, and the y-axes represent relative ASE and the DB index.
Allele specific expression (ASE) analysis with rs615470 in 15 frontal cortices of African ancestry.4a. Davies-Bouldin (DB) validity index analysis. Columns represent the ASE. Dotted line represents the DB validity index. The red dot indicates the optimal d cutoff predicted by the DB index that coincides with ASE. 4b. Concordance of allelic expression variation with heterozygosity. Samples #1 to #5 which show relative allelic expression balance (*ASE<2) are homozygous for all 10 SNPs highlighted. Samples #6 to #15 which show relative allelic expression imbalance are heterozygous for all 10 SNPs. *See material and method for details; ASE: relative allele specific expression.
LLM interpretation
Figure 4a is a combined bar and line graph showing relative allele-specific expression (ASE) for 15 subjects (bars) and the Davies-Bouldin (DB) validity index (line), with a red dot marking the optimal d cutoff. Figure 4b is a table and heatmap showing that samples #1β5, which have lower ASE (<2), are homozygous for 10 highlighted SNPs, while samples #6β15, which exhibit higher ASE, are heterozygous for those same SNPs. The data compares allelic expression imbalance with genotype heterozygosity across the specified samples.
A schematic of CHRNA5 and PSMA4 gene structures.SNPs in red indicate potential functional eQTLs. Note: figure is not drawn to scale.
LLM interpretation
This is a schematic diagram illustrating the gene structures of *PSMA4* and *CHRNA5*. The figure maps various single nucleotide polymorphisms (SNPs) across the genomic region, with specific SNPs highlighted in red to indicate potential functional eQTLs. The genes are represented by blue blocks (exons) and lines (introns), with arrows indicating the direction of transcription.
No entities extracted from this document yet.
No uploaded files.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AmosCI, WuX, BroderickP, GorlovIP, GuJ, et al (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nature genetics 40: 616β622.1838567610.1038/ng.109PMC2713680 | β | β | β |
| BakerTB, WeissRB, BoltD, von NiederhausernA, FioreMC, et al (2009) Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res 11: 785β796.1943604110.1093/ntr/ntp064PMC2699926 | β | β | β |
| BarrettJC, FryB, MallerJ, DalyMJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263β265.1529730010.1093/bioinformatics/bth457 | β | β | β |
| BierutLJ (2011) Genetic vulnerability and susceptibility to substance dependence. Neuron 69: 618β627.2133887510.1016/j.neuron.2011.02.015PMC3095110 | β | β | β |
| BierutLJ, StitzelJA, WangJC, HinrichsAL, GruczaRA, et al (2008) Variants in nicotinic receptors and risk for nicotine dependence. The American journal of psychiatry 165: 1163β1171.1851952410.1176/appi.ajp.2008.07111711PMC2574742 | β | β | β |
| BrownCD, MangraviteLM, EngelhardtBE (2013) Integrative Modeling of eQTLs and Cis-Regulatory Elements Suggests Mechanisms Underlying Cell Type Specificity of eQTLs. PLoS genetics 9: e1003649.2393552810.1371/journal.pgen.1003649PMC3731231 | β | β | β |
| ChatterjeeS, SantosN, HolgateJ, Haass-KofflerCL, HopfFW, et al (2013) The alpha5 subunit regulates the expression and function of alpha4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area. PLoS One 8: e68300.2386921410.1371/journal.pone.0068300PMC3712017 | β | β | β |
| DaniJA, BertrandD (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47: 699β729.1700992610.1146/annurev.pharmtox.47.120505.105214 | β | β | β |
| DaviesDL, BouldinDW (1979) A cluster separation measure. IEEE Trans Pattern Anal Mach Intell 1: 224β227.21868852 | β | β | β |
| DoyleGA, WangMJ, ChouAD, OleynickJU, ArnoldSE, et al (2011) In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. PLoS One 6: e23373.2185809110.1371/journal.pone.0023373PMC3155531 | β | β | β |
| FalvellaFS, AlberioT, NociS, SantambrogioL, NosottiM, et al (2013) Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma. Carcinogenesis 34: 1281β1285.2343081810.1093/carcin/bgt062 | β | β | β |
| FalvellaFS, GalvanA, ColomboF, FrullantiE, PastorinoU, et al (2010) Promoter polymorphisms and transcript levels of nicotinic receptor CHRNA5. Journal of the National Cancer Institute 102: 1366β1370.2073311610.1093/jnci/djq264 | β | β | β |
| FalvellaFS, GalvanA, FrullantiE, SpinolaM, CalabroE, et al (2009) Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk. Clin Cancer Res 15: 1837β1842.1922349510.1158/1078-0432.CCR-08-2107 | β | β | β |
| GruczaRA, WangJC, StitzelJA, HinrichsAL, SacconeSF, et al (2008) A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence. Biol Psychiatry 64: 922β929.1851913210.1016/j.biopsych.2008.04.018PMC2582594 | β | β | β |
| HernandezDG, NallsMA, MooreM, ChongS, DillmanA, et al (2012) Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain. Neurobiol Dis 47: 20β28.2243308210.1016/j.nbd.2012.03.020PMC3358430 | β | β | β |
| HungR, McKayJ, GaborieauV, BoffettaP, HashibeM, et al (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633β637.1838573810.1038/nature06885 | β | β | β |
| JoslynG, BrushG, RobertsonM, SmithTL, KalmijnJ, et al (2008) Chromosome 15q25.1 genetic markers associated with level of response to alcohol in humans. Proc Natl Acad Sci U S A 105: 20368β20373.1906493310.1073/pnas.0810970105PMC2629302 | β | β | β |
| LiuY, LiuP, WenW, JamesMA, WangY, et al (2009) Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1. Cancer Res 69: 7844β7850.1978933710.1158/0008-5472.CAN-09-1833PMC2846106 | β | β | β |
| MiaoX, LeonTY, NganES, SoMT, YuanZW, et al (2010) Reduced RET expression in gut tissue of individuals carrying risk alleles of Hirschsprung's disease. Human molecular genetics 19: 1461β1467.2008953410.1093/hmg/ddq020 | β | β | β |
| Muller PY, Janovjak H, Miserez AR, Dobbie Z (2002) Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: : 1372β1374, 1376, 1378β1379.12074169 | β | β | β |
| NicaAC, PartsL, GlassD, NisbetJ, BarrettA, et al (2011) The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS genetics 7: e1002003.2130489010.1371/journal.pgen.1002003PMC3033383 | β | β | β |
| PaulyJR, MarksMJ, RobinsonSF, van de KampJL, CollinsAC (1996) Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels. J Pharmacol Exp Ther 278: 361β369.8764371 | β | β | β |
| PurcellSNB, Todd-BrownK, ThomasL, FerreiraMA, BenderD, et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559β575.1770190110.1086/519795PMC1950838 | β | β | β |
| SacconeNL, SacconeSF, HinrichsAL, StitzelJA, DuanW, et al (2009) Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 150B: 453β466.10.1002/ajmg.b.30828PMC269330719259974 | β | β | β |
| SacconeSF, HinrichsAL, SacconeNL, ChaseGA, KonvickaK, et al (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human molecular genetics 16: 36β49.1713527810.1093/hmg/ddl438PMC2270437 | β | β | β |
| SchlaepferI, HoftNR, CollinsAC, CorleyRP, HewittJK, et al (2008) The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry 63: 1039β1046.1816397810.1016/j.biopsych.2007.10.024PMC2526976 | β | β | β |
| ShervaR, KranzlerHR, YuY, LogueMW, PolingJ, et al (2010) Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology 35: 1921β1931.2048532810.1038/npp.2010.64PMC3055642 | β | β | β |
| ShervaR, WilhelmsenK, PomerleauCS, ChasseSA, RiceJP, et al (2008) Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with βpleasurable buzzβ during early experimentation with smoking. Addiction 103: 1544β1552.1878350610.1111/j.1360-0443.2008.02279.xPMC2582398 | β | β | β |
| SmithRM, AlachkarH, PappAC, WangD, MashDC, et al (2011) Nicotinic alpha5 receptor subunit mRNA expression is associated with distant 5β² upstream polymorphisms. Eur J Hum Genet 19: 76β83.2070014710.1038/ejhg.2010.120PMC2995013 | β | β | β |
| Spitz MRAC, DongQ, LinJ, WuX (2008) The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 100: 1552β1556.1895767710.1093/jnci/djn363PMC2720751 | β | β | β |
| StevensVL, BierutLJ, TalbotJT, WangJC, SunJ, et al (2008) Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 17: 3517β3525.10.1158/1055-9965.EPI-08-0585PMC261412919029397 | β | β | β |
| ThorgeirssonTE, GellerF, SulemP, RafnarT, WisteA, et al (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638β642.1838573910.1038/nature06846PMC4539558 | β | β | β |
| WangJC, CruchagaC, SacconeNL, BertelsenS, LiuP, et al (2009) Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Human molecular genetics 18: 3125β3135.1944348910.1093/hmg/ddp231PMC2714722 | β | β | β |
| WangJC, GruczaR, CruchagaC, HinrichsAL, BertelsenS, et al (2009) Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Molecular psychiatry 14: 501β510.1841440610.1038/mp.2008.42PMC4381434 | β | β | β |
| WangJC, KapoorM, GoateAM (2012) The genetics of substance dependence. Annu Rev Genomics Hum Genet 13: 241β261.2270317310.1146/annurev-genom-090711-163844PMC3474605 | β | β | β |
| WeissRB, BakerTB, CannonDS, von NiederhausernA, DunnDM, et al (2008) A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS genetics 4: e1000125.1861800010.1371/journal.pgen.1000125PMC2442220 | β | β | β |
| WilkJB, ShrineNR, LoehrLR, ZhaoJH, ManichaikulA, et al (2012) Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 186: 622β632.2283737810.1164/rccm.201202-0366OCPMC3480517 | β | β | β |
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer's disease. | Rybnicek J et al. | β | 2024 | β |
| Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci. | Carnes MU et al. | β | 2024 | β |
| The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19. | Valencia-PΓ©rez Rea D et al. | β | 2023 | β |
| <i>CHRNA5</i>links chandelier cells to severity of amyloid pathology in aging and Alzheimerβs Disease | Rybnicek J et al. | β | 2022 | β |
| Relationship of common variants in CHRNA5 with early-onset schizophrenia and executive function. | Han W et al. | β | 2019 | β |
| Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence. | Hancock DB et al. | β | 2018 | β |
| Human Genetics of Addiction: New Insights and Future Directions. | Hancock DB et al. | β | 2018 | β |
| No evidence of a role of the Ξ²4 subunit of the nicotinic acetylcholine receptor in alcohol-related behaviors. | Kamens HM et al. | β | 2017 | β |
| Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. | Schuit E et al. | β | 2017 | β |
| Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments. | Sakata K et al. | β | 2017 | β |
| An Adolescent Substance Prevention Model Blocks the Effect of CHRNA5 Genotype on Smoking During High School. | Vandenbergh DJ et al. | β | 2016 | β |
| Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans. | Olfson E et al. | β | 2016 | β |
| Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence. | Zuo L et al. | β | 2016 | β |
| A multiancestry study identifies novel genetic associations with CHRNA5 methylation in human brain and risk of nicotine dependence. | Hancock DB et al. | β | 2015 | β |
| Positive Selection on Loci Associated with Drug and Alcohol Dependence. | Sadler B et al. | β | 2015 | β |
| The Ξ²3 subunit of the nicotinic acetylcholine receptor: Modulation of gene expression and nicotine consumption. | Kamens HM et al. | β | 2015 | β |
| DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory. | Di Giorgio A et al. | β | 2014 | β |
| Finding genomic function for genetic associations in nicotine addiction research: the ENCODE project's role in future pharmacogenomic analysis. | Vandenbergh DJ et al. | β | 2014 | β |